Evidence map›Paper›PMID 33321263›Full record

ReviewThe journal of allergy and clinical immunology. In practice2021

Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.

Fatima Bawany, Carrie A Northcott, Lisa A Beck, Wilfred R Pigeon

Open access · greenAbstract readReview
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 5 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 5 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Atopic Dermatitis and Sleep Disorders.Allergy, asthma & immunology research · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Early childhood insomnia phenotypes and temperament: a theoretical review with clinical implications for precision assessment and treatment.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026
    Review
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fatima BawanySchool of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY.
Carrie A NorthcottEarly Clinical Development, Digital Medicine and Translational Imaging, Pfizer, Inc, Cambridge, Mass.
Lisa A BeckDepartment of Dermatology, Medicine and Pathology, University of Rochester Medical Center, Rochester, NY.
Wilfred R PigeonDepartment of Psychiatry, University of Rochester Medical Center, Rochester, NY. Electronic address: Wilfred_Pigeon@urmc.rochester.edu.
University of Rochester Medical Center · USPfizer (United States) · US

Funding

Targeted Microbiome Transplant in Atopic DermatitisU19AI117673 · NIAID · NATIONAL JEWISH HEALTH · PI GEHA, RAIF SALIM · 2015 to 2019
$30.6M
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD PatientsU01AI152011 · NIAID · UNIVERSITY OF ROCHESTER · PI Lisa Ann Beck · 2020 to 2026
$3.2M
The University of Rochester Clinical and Translational Science InstituteTL1TR000096 · NCATS · UNIVERSITY OF ROCHESTER · PI BENNETT, NANCY M, KIEBURTZ, KARL D. · 2012 to 2015
$930k
NCATS NIH HHS TL1 TR000096NIAID NIH HHS U01 AI152011NIAID NIH HHS U19 AI117673
6 · The paper itself

Abstract

Atopic dermatitis is one of the most common chronic inflammatory skin conditions and is associated with sleep disturbances in 47% to 80% of children and 33% to 90% of adults. Herein, we review the literature on sleep disturbances experienced by patients with atopic dermatitis, as well as the mechanisms that may underlie this. We present subjective and objective methods for measuring sleep quantity and quality and discuss strategies for management. Unfortunately, the literature on this topic remains sparse, with most studies evaluating sleep as a secondary outcome using subjective measures. The development of portable, at-home methods for more objective measures offers new opportunities to better evaluate sleep disturbances in atopic dermatitis research studies and in clinical practice.

Indexed as

Dermatitis, AtopicEczemaSleep Wake DisordersAdministration, TopicalAdultChildHumansSleepAtopic dermatitisInsomniaPruritusSleepType 2 immunity

Identifiers

PMID33321263
PMCPMC9026738
OpenAlexW3111797656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.